Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,563 | Dovepress* | 12,563+ | 3,007 | 15,570 | |
Totals | 12,563 | 3,007 | 15,570 | ||
*Since 31 August 2010 +Since July 2016 |
View citations on Google Scholar